{"id":21776,"date":"2016-12-04T05:31:22","date_gmt":"2016-12-04T00:01:22","guid":{"rendered":"https:\/\/cardiophile.org\/?p=21776"},"modified":"2021-12-20T22:44:41","modified_gmt":"2021-12-20T17:14:41","slug":"anticoagulation-for-primary-pci-cardiology-mcq","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-primary-pci-cardiology-mcq\/","title":{"rendered":"Anticoagulation for primary PCI &#8211; Cardiology MCQ"},"content":{"rendered":"<div><span style=\"color: #008000;\"><b>Which of the following should not be used as sole anticoagulant for primary percutaneous coronary angioplasty ?<\/b><\/span><\/div>\n<div><b>\u00a0<\/b><\/div>\n<div>a) Unfractionated heparin<\/div>\n<div><\/div>\n<div>b) Bivalirudin<\/div>\n<div><\/div>\n<div>c) Fondaparinux<\/div>\n<div><\/div>\n<div>d) None of the above<\/div>\n<div><\/div>\n<div><span style=\"color: #0000ff;\"><b>Correct answer: c)\u00a0<\/b><\/span><span style=\"color: #0000ff;\"><b>Fondaparinux<\/b><\/span><\/div>\n<div><b>\u00a0<\/b><\/div>\n<div>If Fondaparinux is used as the sole anticoagulant during primary PCI, there is a higher incidence of catheter thrombosis.<\/div>\n<div><\/div>\n<div>Unfractionated heparin is used in most cases, supplemented if needed, by glycoprotein IIb\/IIIa receptor antagonist if needed in case of significant thrombus load. Some prefer Bivalirudin in cases with a higher bleeding risk instead of the above combination.<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Which of the following should not be used as sole anticoagulant for primary percutaneous coronary angioplasty ? \u00a0 a) Unfractionated heparin b) Bivalirudin c) Fondaparinux d) None of the above Correct answer: c)\u00a0Fondaparinux \u00a0 If Fondaparinux is used as the sole anticoagulant during primary PCI, there is a higher incidence of catheter thrombosis. Unfractionated heparin [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[2,3,5],"tags":[526,706,1529,1594,3018,4093],"class_list":["post-21776","post","type-post","status-publish","format-standard","hentry","category-cardiology","category-cardiology-mcq","category-dm-dnb-cardiology-entrance","tag-bivalirudin","tag-catheter-thrombosis","tag-fondaparinux","tag-glycoprotein-iibiiia-receptor-antagonist","tag-primary-percutaneous-coronary-angioplasty","tag-unfractionated-heparin"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Anticoagulation for primary PCI - Cardiology MCQ - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-primary-pci-cardiology-mcq\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anticoagulation for primary PCI - Cardiology MCQ - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"Which of the following should not be used as sole anticoagulant for primary percutaneous coronary angioplasty ? \u00a0 a) Unfractionated heparin b) Bivalirudin c) Fondaparinux d) None of the above Correct answer: c)\u00a0Fondaparinux \u00a0 If Fondaparinux is used as the sole anticoagulant during primary PCI, there is a higher incidence of catheter thrombosis. Unfractionated heparin [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-primary-pci-cardiology-mcq\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2016-12-04T00:01:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-20T17:14:41+00:00\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-primary-pci-cardiology-mcq\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-primary-pci-cardiology-mcq\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"Anticoagulation for primary PCI &#8211; Cardiology MCQ\",\"datePublished\":\"2016-12-04T00:01:22+00:00\",\"dateModified\":\"2021-12-20T17:14:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-primary-pci-cardiology-mcq\\\/\"},\"wordCount\":97,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"keywords\":[\"Bivalirudin\",\"catheter thrombosis\",\"Fondaparinux\",\"glycoprotein IIb\\\/IIIa receptor antagonist\",\"primary percutaneous coronary angioplasty\",\"Unfractionated heparin\"],\"articleSection\":[\"Cardiology\",\"Cardiology MCQ\",\"DM \\\/ DNB Cardiology Entrance\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-primary-pci-cardiology-mcq\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-primary-pci-cardiology-mcq\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-primary-pci-cardiology-mcq\\\/\",\"name\":\"Anticoagulation for primary PCI - Cardiology MCQ - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"datePublished\":\"2016-12-04T00:01:22+00:00\",\"dateModified\":\"2021-12-20T17:14:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-primary-pci-cardiology-mcq\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-primary-pci-cardiology-mcq\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-primary-pci-cardiology-mcq\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anticoagulation for primary PCI &#8211; Cardiology MCQ\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anticoagulation for primary PCI - Cardiology MCQ - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-primary-pci-cardiology-mcq\/","og_locale":"en_US","og_type":"article","og_title":"Anticoagulation for primary PCI - Cardiology MCQ - All About Cardiovascular System and Disorders","og_description":"Which of the following should not be used as sole anticoagulant for primary percutaneous coronary angioplasty ? \u00a0 a) Unfractionated heparin b) Bivalirudin c) Fondaparinux d) None of the above Correct answer: c)\u00a0Fondaparinux \u00a0 If Fondaparinux is used as the sole anticoagulant during primary PCI, there is a higher incidence of catheter thrombosis. Unfractionated heparin [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-primary-pci-cardiology-mcq\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2016-12-04T00:01:22+00:00","article_modified_time":"2021-12-20T17:14:41+00:00","author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-primary-pci-cardiology-mcq\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-primary-pci-cardiology-mcq\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"Anticoagulation for primary PCI &#8211; Cardiology MCQ","datePublished":"2016-12-04T00:01:22+00:00","dateModified":"2021-12-20T17:14:41+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-primary-pci-cardiology-mcq\/"},"wordCount":97,"commentCount":0,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"keywords":["Bivalirudin","catheter thrombosis","Fondaparinux","glycoprotein IIb\/IIIa receptor antagonist","primary percutaneous coronary angioplasty","Unfractionated heparin"],"articleSection":["Cardiology","Cardiology MCQ","DM \/ DNB Cardiology Entrance"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-primary-pci-cardiology-mcq\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-primary-pci-cardiology-mcq\/","url":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-primary-pci-cardiology-mcq\/","name":"Anticoagulation for primary PCI - Cardiology MCQ - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"datePublished":"2016-12-04T00:01:22+00:00","dateModified":"2021-12-20T17:14:41+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-primary-pci-cardiology-mcq\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-primary-pci-cardiology-mcq\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-primary-pci-cardiology-mcq\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"Anticoagulation for primary PCI &#8211; Cardiology MCQ"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/21776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=21776"}],"version-history":[{"count":1,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/21776\/revisions"}],"predecessor-version":[{"id":52364,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/21776\/revisions\/52364"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=21776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=21776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=21776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}